Abstract |
The study was aimed at determining the vascular expression of oncofetal fibronectin (oncfFn) and tenascin-C (oncfTn-C) isoforms in renal cell carcinoma (RCC) and its metastases which are well-known targets for antibody-based pharmacodelivery. Furthermore, the influence of tumour cells on endothelial mRNA expression of these molecules was investigated. Evaluation of vascular ED-A(+) and ED-B(+) Fn as well as A1(+) and C(+) Tn-C was performed after immunofluorescence double and triple staining using human recombinant antibodies on clear cell, papillary and chromophobe primary RCC and metastases. The influence of hypoxic RCC- conditioned medium on oncfFn and oncfTn-C mRNA expression was examined in human umbilical vein endothelial cells (HUVEC) by real time RT-PCR. There are RCC subtype specific expression profiles of vascular oncfFn and oncfTn-C and corresponding patterns when comparing primary tumours and metastases. Within one tumour, there are different vessel populations with regard to the incorporation of oncfTn-C and oncfFn into the vessel wall. In vitro tumour-derived soluble mediators induce an up regulation of oncfTn-C and oncfFn mRNA in HUVEC which can be blocked by Avastin(®). Vascular expression of oncFn and oncTn-C variants depends on RCC subtype and may reflect an individual tumour stroma interaction or different stages of vessel development. Therefore, oncFn or oncTn-C variants can be suggested as molecular targets for individualized antibody based therapy strategies in RCC. Tumour-derived VEGF could be shown to regulate target expression.
|
Authors | Kerstin Galler, Kerstin Junker, Marcus Franz, Julia Hentschel, Petra Richter, Mieczyslaw Gajda, Angela Göhlert, Ferdinand von Eggeling, Regine Heller, Raffaella Giavazzi, Dario Neri, Hartwig Kosmehl, Heiko Wunderlich, Alexander Berndt |
Journal | Histochemistry and cell biology
(Histochem Cell Biol)
Vol. 137
Issue 2
Pg. 195-204
(Feb 2012)
ISSN: 1432-119X [Electronic] Germany |
PMID | 22075565
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Fibronectins
- Protein Isoforms
- RNA, Messenger
- Tenascin
- Vascular Endothelial Growth Factor A
|
Topics |
- Adenocarcinoma, Clear Cell
(blood supply, pathology, secondary)
- Animals
- Blood Vessels
(metabolism, pathology)
- Carcinoma, Papillary
(blood supply, pathology, secondary)
- Carcinoma, Renal Cell
(blood supply, pathology, secondary)
- Female
- Fibronectins
(metabolism)
- Human Umbilical Vein Endothelial Cells
(metabolism)
- Humans
- Kidney Neoplasms
(blood supply, pathology, secondary)
- Mice
- Mice, Nude
- Neovascularization, Pathologic
- Protein Isoforms
(metabolism)
- RNA, Messenger
(metabolism)
- Tenascin
(metabolism)
- Vascular Endothelial Growth Factor A
(metabolism)
|